Sanofi may ask U.S. Approval for its drug Dengvaxia
Sanofi will decide shortly whether to seek regulatory approval for its dengue vaccine Dengvaxia in the United States and remains...
Personalised medicines, intelligent packaging and FDA deadlines seen as major trends for pharma packaging in 2018
Pharmapack Europe (#pharmapackeu) – organised by UBM – closed its most exciting edition to date, taking place at Paris Expo,...
Alexon pharmaceuticals brings updates on its FY18 Earnings Guidance
Alexion Pharmaceuticals updated its FY18 earnings guidance on Thursday. The company provided earnings per share guidance of $6.60-6.80 for the...
Shire announce its Pivotal study for Hereditary Angioedema at 2018 AAAAI/WAO Joint Congress
Shire plc announced new Phase 3 results from the HELP Study™, a global, multi-center, randomized, double-blind placebo-controlled parallel group trial...
Astellas Receives Approval for XTANDI Tablets, a Treatment for Castration-Resistant Prostate Cancer, in Japan
Astellas Pharma Inc. announced that 40 mg XTANDI Tablets and 80 mg XTANDI Tablets received manufacturing and marketing approval in...
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending...
Lilly, Livongo team up for real-world diabetes research, aiming for better results in an outcomes-oriented market
There's a new tech partnership in diabetes, this time between Eli Lilly and Livongo. And it's looking to tap real-world...
Chinese researchers report first lung stem cell transplantation clinical trial
A research team from Tongji University in China have made a breakthrough in human lung regeneration technology. For the first...
Using injectable self-assembled nanomaterials for sustained delivery of drugs Drug
Because they can be programmed to travel the body and selectively target cancer and other sites of disease, nanometer-scale vehicles...
Gemphire Announces Initiation of Phase 2a Clinical Trial of Gemcabene in Pediatric Non-Alcoholic Fatty Liver Disease
Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia and...
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.